Evidence map›Paper›PMID 35983936›Full record

ArticleAngewandte Chemie (International ed. in English)2022

Stereoselective Three-Step One-Pot Cascade Combining Amino- and Biocatalysis to Access Chiral γ-Nitro Alcohols.

Christian Ascaso-Alegre, Raquel P Herrera, Juan Mangas-Sánchez

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. L-Cysteine-Catalysed Hydration of Activated Alkynes.Angewandte Chemie (International ed. in English) · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Christian Ascaso-AlegreInstitute of Chemical Synthesis and Homogeneous Catalysis (ISQCH), Spanish National Research Council (CSIC)-, University of Zaragoza, Pedro Cerbuna 12, 50009, Zaragoza, Spain.ORCID 0000-0003-0497-8711
Raquel P HerreraInstitute of Chemical Synthesis and Homogeneous Catalysis (ISQCH), Spanish National Research Council (CSIC)-, University of Zaragoza, Pedro Cerbuna 12, 50009, Zaragoza, Spain.ORCID 0000-0002-5244-9569
Juan Mangas-SánchezInstitute of Chemical Synthesis and Homogeneous Catalysis (ISQCH), Spanish National Research Council (CSIC)-, University of Zaragoza, Pedro Cerbuna 12, 50009, Zaragoza, Spain.ORCID 0000-0002-3364-1512

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The combination of small-molecule catalysis and enzyme catalysis represents an underexploited area of research with huge potential in asymmetric synthetic chemistry due to both compatibility of reaction conditions and complementary reactivity. Herein, we describe the telescopic synthesis of chiral nitro alcohols starting from commercially available benzaldehyde derivatives through the one-pot three-step chemoenzymatic cascade combination of a Wittig reaction, chiral-thiourea-catalysed asymmetric conjugate addition, and ketoreductase-mediated reduction to access the corresponding target compounds in moderate to excellent overall isolated yields (36-80 %) and high diastereomeric and enantiomeric ratios (up to >97 : 3). This represents the first example of the combination of an organocatalysed asymmetric conjugate addition via iminium ion activation and a bioreduction step catalysed by ketoreductases.

Indexed as

AlcoholsBenzaldehydesAmino AlcoholsBiocatalysisCatalysisStereoisomerismThioureaAlcoholsAmino AlcoholsBenzaldehydesThioureaAsymmetric SynthesisBiocatalysisChemoenzymatic CascadesOne-Pot ProcessesOrganocatalysis

Identifiers

PMID35983936
PMCPMC9826084

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.